智通财经APP讯，正大企业国际(03839)发布公告，由于中国畜牧业放缓，我们的动保化药产品需求也自2025年第三季随之减少。尽管如此，本集团预期2025年度综合溢利仍将取得增长。本集团预期截至2025年12月31日止年度取得股东应占综合溢利约为3200万美元，相比截至2024年12月31日止年度则取得1120万美元。溢利的增长主要由于收入的大幅增长，反映了我们成功地实施开发大客户销售的关键策略。
本集团截至2025年12月31日止3个月的季度收入将维持在截至2025年9月30日止3个月的相若水平。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.